{"id":"https://openalex.org/W1963713713","doi":"https://doi.org/10.1002/ijc.24604","title":"Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY\u2010142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell lines","display_name":"Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY\u2010142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell lines","alternate_titles":[],"publication_year":2009,"publication_date":"2009-09-18","ids":{"openalex":"https://openalex.org/W1963713713","doi":"https://doi.org/10.1002/ijc.24604","mag":"1963713713","pmid":"https://pubmed.ncbi.nlm.nih.gov/19637312"},"language":"en","primary_location":{"id":"doi:10.1002/ijc.24604","doi":"https://doi.org/10.1002/ijc.24604","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ijc.24604","pdf_url":null,"source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1963713713"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056826438","display_name":"Kathryn Balmanno","orcid":"https://orcid.org/0000-0002-6417-3889","observed_orcids":["https://orcid.org/0000-0002-6417-3889"]},"institutions":[{"id":"https://openalex.org/I1302113299","display_name":"Babraham Institute","ror":"https://ror.org/01d5qpn59","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1302113299","https://openalex.org/I2799693246","https://openalex.org/I4210087105"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kathryn Balmanno","raw_affiliation_strings":["Laboratory of Molecular Signalling, The Babraham Institute, Babraham Research Campus, Cambridge, England, United Kingdom","The first two authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Signalling, The Babraham Institute, Babraham Research Campus, Cambridge, England, United Kingdom","institution_ids":["https://openalex.org/I1302113299"]},{"raw_affiliation_string":"The first two authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049482528","display_name":"Simon D. Chell","orcid":"https://orcid.org/0000-0001-5321-9119","observed_orcids":["https://orcid.org/0000-0001-5321-9119"]},"institutions":[{"id":"https://openalex.org/I1302113299","display_name":"Babraham Institute","ror":"https://ror.org/01d5qpn59","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1302113299","https://openalex.org/I2799693246","https://openalex.org/I4210087105"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon D. Chell","raw_affiliation_strings":["Laboratory of Molecular Signalling, The Babraham Institute, Babraham Research Campus, Cambridge, England, United Kingdom","The first two authors contributed equally to this work"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Signalling, The Babraham Institute, Babraham Research Campus, Cambridge, England, United Kingdom","institution_ids":["https://openalex.org/I1302113299"]},{"raw_affiliation_string":"The first two authors contributed equally to this work","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005362031","display_name":"Annette S. Gillings","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1302113299","display_name":"Babraham Institute","ror":"https://ror.org/01d5qpn59","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1302113299","https://openalex.org/I2799693246","https://openalex.org/I4210087105"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Annette S. Gillings","raw_affiliation_strings":["Laboratory of Molecular Signalling, The Babraham Institute, Babraham Research Campus, Cambridge, England, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Signalling, The Babraham Institute, Babraham Research Campus, Cambridge, England, United Kingdom","institution_ids":["https://openalex.org/I1302113299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090358248","display_name":"Shaista Hayat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1302113299","display_name":"Babraham Institute","ror":"https://ror.org/01d5qpn59","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1302113299","https://openalex.org/I2799693246","https://openalex.org/I4210087105"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Shaista Hayat","raw_affiliation_strings":["Laboratory of Molecular Signalling, The Babraham Institute, Babraham Research Campus, Cambridge, England, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Signalling, The Babraham Institute, Babraham Research Campus, Cambridge, England, United Kingdom","institution_ids":["https://openalex.org/I1302113299"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025815250","display_name":"Simon J. Cook","orcid":"https://orcid.org/0000-0001-9087-1616","observed_orcids":["https://orcid.org/0000-0001-9087-1616"]},"institutions":[{"id":"https://openalex.org/I1302113299","display_name":"Babraham Institute","ror":"https://ror.org/01d5qpn59","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1302113299","https://openalex.org/I2799693246","https://openalex.org/I4210087105"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Simon J. Cook","raw_affiliation_strings":["Laboratory of Molecular Signalling, The Babraham Institute, Babraham Research Campus, Cambridge, England, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Signalling, The Babraham Institute, Babraham Research Campus, Cambridge, England, United Kingdom","institution_ids":["https://openalex.org/I1302113299"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5025815250"],"corresponding_institution_ids":["https://openalex.org/I1302113299"],"apc_list":{"value":5030,"currency":"USD","value_usd":5030},"apc_paid":null,"fwci":3.325,"has_fulltext":false,"cited_by_count":152,"citation_normalized_percentile":{"value":0.9352945,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"125","issue":"10","first_page":"2332","last_page":"2341"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9258000254631042,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9258000254631042,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.05510000139474869,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selumetinib","display_name":"selumetinib","score":0.9729999899864197},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.7979999780654907},{"id":"https://openalex.org/keywords/intrinsic-drug-resistance","display_name":"intrinsic drug resistance","score":0.796999990940094},{"id":"https://openalex.org/keywords/colorectal-cancer-cell-lines","display_name":"colorectal cancer cell lines","score":0.9210000038146973},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.9700000286102295},{"id":"https://openalex.org/keywords/pi3k-signaling","display_name":"PI3K signaling","score":0.9900000095367432},{"id":"https://openalex.org/keywords/akt","display_name":"Akt","score":0.7590000033378601},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.7390000224113464},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":1.0},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.906000018119812},{"id":"https://openalex.org/keywords/pi3k-mtor-inhibitors","display_name":"PI3K/mTOR inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7580000162124634},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.6340000033378601},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8360000252723694},{"id":"https://openalex.org/keywords/g1-cell-cycle-arrest","display_name":"G1 cell cycle arrest","score":0.9200000166893005}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.8921864032745361},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.636188268661499},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5700469017028809},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5438864231109619},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5253152847290039},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5133220553398132},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.4850972890853882},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.4737972617149353},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.42508330941200256},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.39393338561058044},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29824399948120117},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.25633758306503296},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15999874472618103},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.055455297231674194}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D034741","descriptor_name":"RNA, Small Interfering","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048052","descriptor_name":"Mitogen-Activated Protein Kinase 3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D048052","descriptor_name":"Mitogen-Activated Protein Kinase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D048369","descriptor_name":"MAP Kinase Kinase 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D048369","descriptor_name":"MAP Kinase Kinase 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D048370","descriptor_name":"MAP Kinase Kinase 2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D048370","descriptor_name":"MAP Kinase Kinase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/ijc.24604","doi":"https://doi.org/10.1002/ijc.24604","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ijc.24604","pdf_url":null,"source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:19637312","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19637312","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of cancer","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2012023987","display_name":null,"funder_award_id":"BBS/E/B/0000C199","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"},{"id":"https://openalex.org/G7215072125","display_name":null,"funder_award_id":"BB/C509190/1","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320334629","display_name":"Biotechnology and Biological Sciences Research Council","ror":"https://ror.org/00cwqg982"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W1494491432","https://openalex.org/W1575730129","https://openalex.org/W1966133006","https://openalex.org/W1967835627","https://openalex.org/W1980135491","https://openalex.org/W1980791048","https://openalex.org/W1981269760","https://openalex.org/W1989480480","https://openalex.org/W1990298698","https://openalex.org/W1990750564","https://openalex.org/W1991738330","https://openalex.org/W1993075812","https://openalex.org/W2000449597","https://openalex.org/W2000896073","https://openalex.org/W2001999652","https://openalex.org/W2004558792","https://openalex.org/W2017821413","https://openalex.org/W2017901820","https://openalex.org/W2024232981","https://openalex.org/W2027737365","https://openalex.org/W2028752124","https://openalex.org/W2035939293","https://openalex.org/W2036614475","https://openalex.org/W2040602576","https://openalex.org/W2041098455","https://openalex.org/W2043243100","https://openalex.org/W2044210875","https://openalex.org/W2059192510","https://openalex.org/W2066093835","https://openalex.org/W2077247436","https://openalex.org/W2080686146","https://openalex.org/W2080719056","https://openalex.org/W2085483616","https://openalex.org/W2086939775","https://openalex.org/W2087012714","https://openalex.org/W2106930740","https://openalex.org/W2108958930","https://openalex.org/W2115484306","https://openalex.org/W2115779497","https://openalex.org/W2118468498","https://openalex.org/W2123611729","https://openalex.org/W2123885531","https://openalex.org/W2124593509","https://openalex.org/W2124662474","https://openalex.org/W2129172946","https://openalex.org/W2129429534","https://openalex.org/W2134490812","https://openalex.org/W2136222819","https://openalex.org/W2144040817","https://openalex.org/W2155299791","https://openalex.org/W2159594827","https://openalex.org/W2162147795","https://openalex.org/W2163188200","https://openalex.org/W2163295338","https://openalex.org/W2165023373","https://openalex.org/W2320926313"],"related_works":["https://openalex.org/W2027178287","https://openalex.org/W2247511177","https://openalex.org/W2170138574","https://openalex.org/W1649308583","https://openalex.org/W2099516828","https://openalex.org/W2007867839","https://openalex.org/W2135707008","https://openalex.org/W2120341265","https://openalex.org/W2923523446","https://openalex.org/W2080369972"],"abstract_inverted_index":{"Mutations":[0],"in":[1,7,34,69,107,189,252],"KRAS":[2,86,118,197],"or":[3,39,85,117,136,140,196,218],"BRAF":[4,49,84,116,195,217],"frequently":[5],"manifest":[6],"constitutive":[8],"activation":[9,22,139,143,155],"of":[10,47,72,115,144,154,156,177,249],"the":[11,45,57,113,151,157,178,247],"MEK1/2-ERK1/2":[12],"signalling":[13],"pathway.":[14,159],"The":[15],"MEK1/2-selective":[16],"inhibitor,":[17],"AZD6244":[18,133,171,186,232],"(ARRY-142886),":[19],"blocks":[20],"ERK1/2":[21,138,145,165,212],"and":[23,44,78,88,112,146,166,226],"is":[24,51,187],"currently":[25],"undergoing":[26],"clinical":[27],"evaluation.":[28],"Tumour":[29],"cells":[30,93,209],"can":[31,235],"vary":[32],"markedly":[33],"their":[35],"response":[36],"to":[37,53,90,99,123,132,170,200,228,231],"MAPK":[38],"ERK":[40],"kinase":[41,148],"(MEK)":[42],"inhibitors,":[43],"presence":[46,114],"a":[48,70,205,221],"mutation":[50,87,97,119],"thought":[52],"predict":[54,124],"sensitivity,":[55],"with":[56,62,163,194,204,210,254],"RAS":[58],"mutations":[59],"being":[60],"associated":[61],"intrinsic":[63],"resistance.":[64],"We":[65,183],"analysed":[66],"cell":[67,76,161,192],"proliferation":[68],"panel":[71],"19":[73],"colorectal":[74,190],"cancer":[75,191],"lines":[77,128,162,193],"found":[79],"no":[80,137],"simple":[81],"correlation":[82],"between":[83],"sensitivity":[89,169],"AZD6244,":[91],"though":[92],"that":[94,103,129,185,224],"harbour":[95],"neither":[96],"tended":[98],"be":[100,173,229,236],"resistant.":[101],"Cells":[102],"were":[104,130],"sensitive":[105,230],"arrested":[106],"G(1)":[108],"and/or":[109],"underwent":[110],"apoptosis":[111],"was":[120],"not":[121],"sufficient":[122],"either":[125],"fate.":[126],"Cell":[127],"resistant":[131],"exhibited":[134,141],"low":[135],"coincident":[142,164],"protein":[147],"B":[149],"(PKB),":[150],"latter":[152],"indicative":[153],"PI3K":[158,255],"In":[160],"PKB":[167],"activation,":[168],"could":[172],"re-imposed":[174],"by":[175,238],"any":[176],"3":[179],"distinct":[180],"PI3K/mTOR":[181],"inhibitors.":[182,256],"conclude":[184],"effective":[188],"mutations.":[198],"Sensitivity":[199],"MEK1/2":[201],"inhibition":[202],"correlates":[203],"biochemical":[206],"signature;":[207],"those":[208],"high":[211,239],"activity":[213],"(whether":[214],"mutant":[215],"for":[216,246],"KRAS)":[219],"evolve":[220],"dependency":[222],"upon":[223],"pathway":[225],"tend":[227],"but":[233],"this":[234],"offset":[237],"PI3K-dependent":[240],"signalling.":[241],"This":[242],"may":[243],"have":[244],"implications":[245],"use":[248],"MEK":[250],"inhibitors":[251],"combination":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1963713713","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":20},{"year":2014,"cited_by_count":15},{"year":2013,"cited_by_count":20},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
